CUPPENS, Kristof

Email Alert RSS Feed

Profile

Full Name
CUPPENS, Kristof
Email
kristof.cuppens@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 1-20 of 23 (Search time: 0.001 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
12025A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancerVOLDERS, Pieter-Jan; Aftimos, Philippe; Dedeurwaerdere, Franceska; Martens, Geert; Canon, Jean-Luc; Beniuga, Gabriela; Van Huysse, Jacques; FROYEN, Guy; De Pauw, Rebecca; Prenen, Hans; Lambin, Suzan; Decoster, Lore; Vaeyens, Freya; Rottey, Sylvie; Van Dam, Pieter-Jan; Decoster, Lynn; Rutten, Annemie; Schreuer, Max; Loontiens, Siebe; van der Meulen, Joni; MEBIS, Jeroen; CUPPENS, Kristof; Tejpar, Sabine; Vanden Bempt, Isabelle; De Greve, Jacques; Schroeder, David; van Marcke, Cedric; van den Bulcke, Marc; de Azambuja, Evandro; Punie, Kevin; MAES, BrigitteJournal ContributionA1
22025Impact of anti-PD-1 Treatment on DSA Generation in Cancer PatientsPlanel, S; Vayssière, G; Vichier, C; Puget, C; Gérard, M; Devos , B; Cantero, F; Sibille, A; Demedts, I; Tostivint, EP; van de Kerkhove, C; Derijcke, S; Theelen, W; Biesma, B; Borm, F; Colinet, B; Wauters , E; Moro-Sibilot, D; Perol, M; Buchmeier, EL; Skrzypski, M; CUPPENS, Kristof; Vansteenkiste, J; Debruyne, C; Bardy, B; Maggipinto, G; Plumas, JJournal ContributionM
32024Krascendo-170 Lung: A phase Ib/II study of divarasib + pembrolizumab ± platinum-based chemotherapy and pemetrexed in untreated KRAS G12C+advanced non-small cell lung cancer (NSCLC)Skoulidis, Ferdinandos; CUPPENS, Kristof; Sacher, Adrian G.; Velcheti, Vamsidhar; Lee , Dae Ho; Lin, Mark T.; Fernando, Tharu M.; Li, Shuai; Bradley, Denise; Crnkovic, Martina Zarak; Mathisen, MichaelJournal ContributionM
42024Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous EGFR-Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY TrialCamidge, D. Ross; Bar, Jair; Horinouchi, Hidehito; Goldman, Jonathan; Moiseenko, Fedor; Filippova, Elena; Cicin, Irfan; Ciuleanu, Tudor; Daaboul, Nathalie; Liu, Chunling; Bradbury, Penelope; Moskovitz, Mor; Katgi, Nuran; Tomasini, Pascale; Zer, Alona; Girard, Nicolas; CUPPENS, Kristof; Han, Ji-Youn; Wu, Shang-Yin; Baijal, Shobhit; Mansfield, Aaron S.; Kuo, Chih-Hsi; Nishino, Kazumi; Lee, Se-Hoon; Planchard, David; Baik, Christina; Li, Martha; Ansell, Peter; Xia, Summer; Bolotin, Ellen; Looman, Jim; Ratajczak, Christine; Lu, ShunJournal ContributionA1
52024Immune checkpoint inhibition in early-stage non-small cell lung cancerCUPPENS, Kristof; Du Pont, Bert; Knegjens, Joost; MAES, Brigitte; Baas, PaulJournal ContributionA1
62024The Adenosinergic Pathway in Non-Small Cell Lung CancerVan Kerkhove, Olivier; Verfaillie, Saartje; MAES, Brigitte; CUPPENS, KristofJournal ContributionA1
72024Is Intravenous and Oral Topotecan in Small-Cell Lung Cancer Truly Equal? A Case ReportDeraedt, Davien; Verfaillie, Saartje; Wynants, Jokke; CUPPENS, KristofJournal ContributionA2
82024Neoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-upCUPPENS, Kristof; Baas, P.; Wiesweg, M.; Du Pont, B.; Ploenes, T.; Theegarten, D.; Aigner, C.; Hartemink, K.; MAES, Brigitte; Pat, K.; Schuler, M.Journal ContributionM
92024Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trialSchuler, Martin; CUPPENS, Kristof; Ploenes, Till; Wiesweg, Marcel; Du Pont, Bert; Hegedus, Balazs; Koester, Johannes; Mairinger, Fabian; Darwiche, Kaid; Paschen, Annette; MAES, Brigitte; Vanbockrijck, Michel; Laehnemann, David; Zhao, Fang; Hautzel, Hubertus; Theegarten, Dirk; Hartemink, Koen; Reis, Henning; Baas, Paul; Schramm, Alexander; Aigner, ClemensJournal ContributionA1
102023Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 TrialCho, Byoung Chul; Lee, Jong Seok; Wu , Yi-Long; Cicin, Irfan; Dols, Manuel Cobo; Ahn, Myung-Ju; CUPPENS, Kristof; Veillon, Remi; Nadal, Ernest; Dias, Josiane Mourao; Martin, Claudio; Reck, Martin; Garon, Edward B.; Felip, Enriqueta; Paz-Ares, Luis; Mornex, Francoise; Vokes, Everett E.; Adjei, Alex A.; Robinson, Clifford; Sato, Masashi; Vugmeyster, Yulia; Machl, Andreas; Audhuy, Francois; Chaudhary, Surendra; Barlesi, FabriceJournal ContributionA1
112023Reliability of panel-based mutational signatures for immune-checkpoint-inhibition efficacy prediction in non-small cell lung cancerDonker, H. C.; CUPPENS, Kristof; FROYEN, Guy; Groen, H. J. M.; Hiltermann, T. J. N.; MAES, Brigitte; Schuuring, E.; Volders, P. -J.; Lunter, G. A.; van Es, B.Journal ContributionA1
122023Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical ApplicationsVandekerckhove, Olivia; CUPPENS, Kristof; Pat, Karin; Du Pont, Bert; FROYEN, Guy; MAES, BrigitteJournal ContributionA1
332023Sjogren's Syndrome Caused by PD-1 Inhibition in a Lung Cancer PatientCaeyman, Aaron; Vandekerckhove, Olivia; Pat, Karin; Wynants, Jokke; Weytjens, Karolien; de Wergifosse, Isabelle; CUPPENS, KristofJournal ContributionA1
342023Datopotamab Deruxtecan (Dato-DXd) plus Durvalumab ± Carboplatin in Advanced/mNSCLC: Initial Results from Phase 1b TROPION-Lung04Papadopoulos, K. P.; Bruno, D.; Kitazono, S.; Murakami, S.; Gutierrez, M.; Wakuda, K.; Spira, A.; CUPPENS, Kristof; Lovick, S.; Hepner, A.; Mak, G.; Waqar, S. N.Journal ContributionM
352023UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)Bar, Jair; Peled, Nir; Schokrpur, Shiruyeh; Wolner, Mirjana; Rotem, Ofer; Girard, Nicolas; Nana, Frank Aboubakar; Derijcke, Sofie; Kian, Waleed; Patel, Sandip; Gantz-Sorotsky, Hadas; Zer, Alona; Moskovitz, Mor; Metro, Giulio; Rottenberg, Yakir; Calles, Antonio; Hochmair, Maximilian; CUPPENS, Kristof; Decoster, Lynn; Reck, Martin; Limon, Dror; Rodriguez, Estelamari; Astaras, Christoforos; Bettini, Adrienne; Hafliger, Simon; Addeo, AlfredoJournal ContributionA1
362023The path forward in early-stage lung cancerCUPPENS, Kristof; Baas, PaulJournal ContributionA2
372022Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and TreatmentAgbarya, Abed; Shalata, Walid; Addeo, Alfredo; Charpidou, Andriani; CUPPENS, Kristof; Brustugun, Odd Terje; Rajer, Mirjana; Jakopovic, Marco; Marinca, Mihai, V; Pluzanski, Adam; Hiltermann, Jeroen; Araujo, AntonioJournal ContributionA1
382022Open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC)Vansteenkiste, J. F.; Demedts, I.; Pons-Tostivint, E.; Biesma, B.; Borm, F.; Colinet, B.; CUPPENS, Kristof; Derijcke, S.; Greillier, L.; Juergens, J.; Moro-Sibilot, D.; Perol, M.; Sebastian, M.; Skrzypski, M.; Theelen, W.; Van De Kerkhove, C.; Collodoro, M.; Plumas, J.; Debruyne, C.; Sibille, A.Journal ContributionM
192022Uncommon EGFR mutations on osimertinib, real-life data (UNICORN study): Updated results, brain efficacy, and resistance mechanismsBar, Jair; Peled, Nir; Schokrpur, Shiruyeh; Dudnik, Elizabeth; Wollner, Mira; Girard, Nicolas; Nana, Frank Aboubakar; Derijcke, Sofie; Kian, Waleed; Patel, Sandip P.; Sorotsky, Hadas Yocheved Gantz; Zer, Alona; Moskovitz, Mor; Metro, Giulio; Rottenberg, Yakir; Calles, Antonio; Hochmair, Maximilian; CUPPENS, Kristof; Decoster, Lynn; Addeo, AlfredoJournal ContributionM
202022A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung)Schuler, M. H. H.; CUPPENS, Kristof; Ploenes, T.; Vanbockrijck, M.; Wiesweg, M.; Darwiche, K.; Schramm, A.; MAES, Brigitte; Hegedus, B.; Schildhaus, H-U.; Hautzel, H.; Theegarten, D.; Baas, P.; Hartemink, K.; Du Pont, B.; Aigner, C.Journal ContributionM
show all